Echocardiographic Imaging in Clinical Trials: American Society of Echocardiography Standards for Echocardiography Core Laboratories : Endorsed by the American College of Cardiology Foundation - 24/08/11
Durham, North Carolina; Chicago, Illinois; New York, New York; Hackensack, New Jersey; Cleveland, Ohio; Rochester, Minnesota; Boston, Massachusetts; Portland, Oregon; Washington, DC
Plan
| Richard B. Devereux is a lecturer and member of the Scientific Advisory Committee for Merck & Company (Whitehouse Station, NJ), and a consultant for Novartis (Basel, Switzerland). Michael H. Picard is a consultant for Acusphere (Tewksbury, MA). Kevin Wei receives research support from GE Healthcare (Milwaukee, WI) and Lantheus Medical Imaging (North Billerica, MA). |
|
| Conflicts of Interest: The authors have no conflicts of interest to disclose except as noted above. Supporters of the authors’ current core laboratory projects are listed below. |
|
| Research Support for Core Lab Projects: Pamela S. Douglas: Atritech (Plymouth, MA), Edwards Lifesciences (Irvine, CA), Osiris Medical (El Paso, TX), ABIOMED (Danvers, MA), Viacor (Wilmington, MA), and Amgen (Thousand Oaks, CA). Richard B. Devereux: National Heart, Lung, and Blood Institute (NHLBI; Bethesda, MD). Shelly Duckworth: Atritech, Edwards Lifesciences, Osiris Medical, ABIOMED, Viacor, Amgen. Julius M. Gardin: Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (NHLBI). Wael A. Jaber: Athersys (Cleveland, OH) Cardiovascular Cell Therapy Research Network (CCTRN), NHLBI, Aastrom Biosciences (Ann Arbor, MI) (in collaboration with ICON Medical Imaging, Warrington, PA), Juventas Therapeutics (formerly AcelleRX, Cleveland, OH), KAI Pharmaceuticals (South San Francisco, CA), Mannkind Corporation (Valencia, CA), and Medtronic (Minneapolis, MN). Annitta J. Morehead: Athersys, CCTRN, NHLBI, Aastrom (in collaboration with ICON Medical Imaging), Juventas Therapeutics (formerly AcelleRX), KAI Pharmaceuticals, Mannkind Corporation, and Medtronic. Michael H. Picard: Edwards Lifesciences. Scott D. Solomon: NHLBI, Abbott Laboratories (Abbott Park, IL), Boston Scientific Corporation (Natick, MA), Cardiac Dimensions (Kirkland, WA), Daiichi Sankyo (Tokyo, Japan), Forest Research Institute (New York, NY), Guided Delivery Systems (Santa Clara, CA), Hamilton Health Sciences (Hamilton, Canada), and Novartis. Neil J. Weissman: NHLBI, Spectranetics (Colorado Springs, CO), Labcoat Limited (Galway, Ireland), Boston Scientific Corporation, Atrium Medical Corporation (Hudson, NH), Cook Medical (Bloomington, IN), ATS Medical (Minneapolis, MN), Sorin/CarboMedics (Austin, TX), Edwards Lifescience, St Jude Medical (St Paul, MN), BIOTRONIK (Berlin, Germany), Novartis, Sunshine Heart (Tustin, CA), MitralSolutions (Fort Lauderdale, FL), Ample Medical (Foster City, CA), Evalve (Menlo Park, CA), Mitralign (Tewksbury, MA), Medispec (Germantown, MD), and Direct Flow Medical (Santa Rosa, CA). |
|
| Reprint requests: American Society of Echocardiography, 2100 Gateway Centre Boulevard, Suite 310, Morrisville, NC 27560 (E-mail: ase@asecho.org). |
Vol 22 - N° 7
P. 755-765 - juillet 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
